Oberweis Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-163,570
Closed -$11.3M 222
2024
Q1
$11.3M Sell
163,570
-14,900
-8% -$1.01M 0.82% 42
2023
Q4
$11.1M Buy
178,470
+16,850
+10% +$943K 1.03% 15
2023
Q3
$9.07M Buy
161,620
+36,180
+29% +$2.04M 0.96% 15
2023
Q2
$6.33M Buy
125,440
+29,700
+31% +$1.58M 0.77% 30
2023
Q1
$5.22M Buy
+95,740
New +$5.59M 0.81% 22

Other funds holding AXNX

Oberweis Asset Management's AXNX Position: Q2 2024 in Review

Oberweis Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2024, closing a stake of 163,570 shares — an estimated $11.3M sold.

Oberweis Asset Management first reported a position in AXNX in Q1 2023 and held it in 5 quarters. The position peaked at $11.3M in Q1 2024. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2024.

  • Oberweis Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Oberweis Asset Management sold 163,570 Axonics, Inc. Common Stock shares in Q2 2024, an estimated $11.3M.
  • Oberweis Asset Management first reported a position in Axonics, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
  • Oberweis Asset Management's Axonics, Inc. Common Stock position peaked at $11.3M in Q1 2024.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2024.

Based on Oberweis Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.